Devices for the screening of diabetes complications
We are the market leader in the field of electronic health record for the management of diabetes, with a coverage of over 90% of the Italian market.
Our activity is divided into two main branches: software development and manufacturing of medical devices.
Our company produces three devices for the screening of the diabetes complications:
• Biothesiomer Plus: designed to detect sensory deficit and measure the threshold of appreciation of vibration in diabetic patients or in any other cases in which this kind of assessment is required.
• TermoSkin: a portable electromedical device for measuring skin temperature without physical contact in order to perform tests to assess a patient’s thermal discrimination threshold and to compare temperatures in different parts of the body.
• NeuroTester Air: a guided medical device for performing and processing Cardiac Autonomic Neuropathy tests that evaluate changes in the autonomic nervous system in the Diabetic Autonomic Neuropathy (DAN) diagnosis.
Let me know if you are interested to distribute our products in Israel.
Company Info:
Year of establishment: 2002
No. of employees: 36